132210-24-3 Usage
General Description
The chemical 2-AMINO-3-(1,2-DIHYDRO-2-OXOQUINOLINE-4-YL)PROPANOIC ACID HYDROCHLORIDE is a hydrochloride salt of a compound with the molecular formula C13H13N2O3Cl. It is an amino acid derivative with a quinoline ring substitution and a carboxylic acid functional group. 2-AMINO-3-(1,2-DIHYDRO-2-OXOQUINOLINE-4-YL)PROPANOIC ACID HYDROCHLORIDE may have potential pharmacological activity due to its structural features, and further research could be conducted to explore its potential applications in medicine and chemistry. The hydrochloride salt form indicates that the compound is water-soluble and may have different properties and uses compared to the parent compound.
Check Digit Verification of cas no
The CAS Registry Mumber 132210-24-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,2,1 and 0 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 132210-24:
(8*1)+(7*3)+(6*2)+(5*2)+(4*1)+(3*0)+(2*2)+(1*4)=63
63 % 10 = 3
So 132210-24-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H12N2O3/c13-9(12(16)17)5-7-6-11(15)14-10-4-2-1-3-8(7)10/h1-4,6,9H,5,13H2,(H,14,15)(H,16,17)
132210-24-3Relevant articles and documents
Preparation method of rebamipide bulk drug
-
Paragraph 0012; 0029; 0034; 0038; 0043; 0047; 0052, (2021/08/14)
The invention discloses a preparation method of a rebamipide bulk drug. The preparation method comprises the following steps: 1, preparing a crude product of the rebamipide bulk drug: preparing the crude product of the rebamipide bulk drug by utilizing a compound III and 4-chlorobenzoyl chloride; and 2, purifying the rebamipide bulk drug. The compound III is prepared from a compound II, deionized water and concentrated hydrochloric acid, the compound II is prepared from a compound I, glacial acetic acid and concentrated hydrochloric acid, and the compound I is prepared from diethyl acetamidomalonate and 4-bromomethylquinolone. A process control method is utilized, impurities in the synthesized compound I, impurities in the synthesized compound II and impurities in the synthesized compound III are respectively subjected to impurity removal and purification by a common purification method, and the purity of the rebamipide bulk drug is improved in combination with a method for crystallizing and purifying the crude product of the rebamipide bulk drug.
